Infectious disease therapeutics market is likely to witness an excellent growth rate due to rising cases of infectious disease across the world. In several countries the lack of awareness among the huge population, poor hygiene and lack of adequate diagnosis fuelling demand for the infectious disease therapeutics.
Public health is widely exposed to deadly diseases such as HIV, tuberculosis, hepatitis A & C, dengue, and malaria. In most of the cases the patients get infected with deadly viruses such as the HIV virus reduces the overall power of the immune system. The prevention of other infection and improve the immunity of the patients strongly requires superior medications and diagnosis is projected to boost market growth.
Global infectious disease therapeutics market is segmented based on the mode of treatment as drugs, and vaccines. On the basis of drug class, the global infectious disease therapeutics market is segregated as anti-bacterial, anti-viral, anti-parasite, and anti-fungal. Anti-viral is expected to witness notable gains in the forecast years. On the basis of disease indication, the global infectious disease therapeutics market is segregated as tuberculosis, HIV/AIDS, influenza, and hepatitis. The report segments global infectious disease therapeutics market based on end-user as hospital pharmacy and retail pharmacy.
Global infectious disease therapeutics market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional infectious disease therapeutics market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global infectious disease therapeutics market share consists of several players including Novartis AG, Astellas Pharma, Bayer AG, AbbVie, Merck, AstraZeneca plc, Eli Lilly and Company, Bristol-Myers Squibb, and Cubist.
The Infectious Disease Therapeutics Market has been segmented as below:
Infectious Disease Therapeutics Market, By Mode of Treatment
Infectious Disease Therapeutics Market, By Drug Class
Infectious Disease Therapeutics Market, By Disease Indication
Infectious Disease Therapeutics Market, By End-User
Infectious Disease Therapeutics Market, By Region
The report covers:
Report scope:
The global infectious disease therapeutics market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Novartis AG, Astellas Pharma, Bayer AG, AbbVie, Merck, AstraZeneca plc, Eli Lilly and Company, Bristol-Myers Squibb, and Cubist.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Sutureless Aortic Valve Market
Tissue Processing Systems Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Driver 1
4.2.2. Driver 2
4.2.3. Driver 3
4.3. Restraints
4.3.1. Restraint 1
4.3.2. Restraint 2
4.4. Opportunities
4.4.1. Opportunity 1
4.4.2. Opportunity 2
4.5. Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
5. Infectious Disease Therapeutics Market, By Mode of Treatment
5.1. Key Points
5.2. Drugs
5.3. Vaccines
6. Infectious Disease Therapeutics Market, By Drug Class
6.1. Key Points
6.2. Anti-Bacterial
6.3. Anti-Viral
6.4. Anti-Parasite
6.5. Anti-Fungal
7. Infectious Disease Therapeutics Market, By Disease Indication
7.1. Key Points
7.2. Tuberculosis
7.3. HIV/AIDS
7.4. Influenza
7.5. Hepatitis
8. Infectious Disease Therapeutics Market, By End-User
8.1. Key Points
8.2. Hospitals Pharmacy
8.3. Retails Pharmacy
9. Competitive Landscape
9.1. Introduction
9.2. Recent Developments
9.2.1. Mergers & Acquisitions
9.2.2. New Product Developments
9.2.3. Portfolio/Production Capacity Expansions
9.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.2.5. Others
10. Company Profile
10.1. Novartis AG
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. Astellas Pharma
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Bayer AG
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. AbbVie,
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Merck
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. AstraZeneca Plc
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Eli Lilly and Company
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. Bristol-Myers Squibb
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Cubist
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
The Infectious Disease Therapeutics Market has been segmented as below:
Infectious Disease Therapeutics Market, By Mode of Treatment
Infectious Disease Therapeutics Market, By Drug Class
Infectious Disease Therapeutics Market, By Disease Indication
Infectious Disease Therapeutics Market, By End-User
Infectious Disease Therapeutics Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
